May 15, 2017 Columns by Ed Tobias MS News That Caught My Eye: Ocrevus Q&A, Cheap SPMS Therapy in Testing, and New Research In case you missed them, here are some news stories that appeared in MS News Today that caught my eye over the past week. MSAA’s Dr. Jack Burks Responds to Readers’ Questions About Ocrevus and Its Use All over the internet MS patients are asking questions about…
May 8, 2017 Columns by Ed Tobias MS News That Caught My Eye: Cannabis Gum, Ocrevus, Misdiagnosis and Other Stories The MS Wire is adding a third weekly item, beginning today. It’s a list of several news items that appeared in MS News Today over the preceding week and that caught my eye. Axim Signs Deal to Advance Clinical Trials of Cannabis-based MedChew Rx Gum to…
April 10, 2017 Columns by admin Pick of the Week’s News: Progression, Antibiotics, Ocrevus, Stem Cells, B-Cells Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Canada, World’s Multiple Sclerosis Capital, Launches 3-Way Collaboration to Research MS Progression Why some people develop primary progressive MS and others have the relapsing type, and why a many relapsing patients develop secondary…
April 3, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Ocrevus and Its Approval, Reactions, Development, Dispensing, Other Countries Today, my Pick of the Week’s News is devoted to various news stories, all published by Multiple Sclerosis News Today, about FDA approval of Genentech’s Ocrevus as an MS treatment. FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive Forms Last week’s approval of Ocrevus (ocrelizumab) by…
March 27, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Clinical Trials, Rebif, Swallowing, Euthanasia, Patent Here’s my Pick of the Week’s News, as published in Multiple Sclerosis News Today. National MS Society-Sponsored Group Creates Tool Set to Measure Outcomes in MS Clinical Trials Speeding up clinical trials should have the knock-on effect of shortening the whole process of developing and approving new…
March 20, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Ocrevus, Myelin, Telemedicine, Gala and Axon Here is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Ocrevus and the hope of ‘ending MS forever’: Interview with MS Society’s Tim Coetzee Ocrevus possibly being one of the most significant advances in MS treatment, especially for people with PPMS, the…
March 13, 2017 by admin MS Patient’s Pick of the Week’s News: Useless Liberation Therapy, Immune System, After Obamacare, Aging with SPMS, IsolateMS Here is my Pick of the Week’s News, as published in Multiple Sclerosis News Today. ‘Liberation Therapy’ Is Useless, Costly, Potentially Dangerous, Study Finds At last, some positive research to debunk a supposed treatment that is not supported by any genuine repeatable research. To hear this ridiculous…
March 6, 2017 Columns by admin MS Patient’s Pick of the Week’s News: #MySupportHero, Awareness Video, Mind and Mobility, Seizures, Acthar Gel Here’s my Pick of the Week’s News, as published in Multiple Sclerosis News Today. MS Organizations Join #MySupportHero Initiative to Help Patients Salute Those Who Care Oh, I can see me fitting in well here. To see what I mean, just take a look at two previous…
February 27, 2017 Columns by admin #ACTRIMS2017 – MS Patient’s Pick of the Week’s News The ACTRIMS 2017 Forum is the source of my Pick of the Week’s News as published in Multiple Sclerosis News Today. There is Increased Evidence Linking Viruses to MS Risk This evidence goes some way toward justifying my view, previously published, about connections between viruses and MS. In particular,…
February 20, 2017 Columns by admin MS Patient’s Pick of the Week’s News: BFitLifestyles, Cannabis, ARNet, Bioness and More Here`s my Pick of the Week’s News as published by Multiple Sclerosis News Today. Fitness Trainer and MS Patient, Dolly Stokes, Launches BFitLifestyles Website with Husband Looking after what you eat and exercising according to your abilities apparently can help alleviate symptoms of many chronic illnesses including…
February 13, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Obamacare, Traditional Medicine, Insoles, Biomarkers, Massage Here’s my Pick of the Week’s News as published in Multiple Sclerosis News Today. People with Chronic Diseases Support Obamacare More Than General Public, Survey Finds As everyone must know, throughout the world, politics in the U.S. has become extremely volatile and one of the focuses is…
February 6, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Stem Cells, Cognitive, Gilenya, Tecfidera, Zinbryta Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Clinical Trial Supports Stem Cell Transplants to Treat RMS Patients with High Disease Activity It’s no secret to readers of this column and, indeed, to the wider MS community, that I am convinced…
January 30, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Sense of Smell, Women, Biomarkers and More Here is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Sense of Smell Impaired in Half of Multiple Sclerosis Patients in Study For very many years I have known that my sense of smell has not been as good as that considered normal…
January 23, 2017 Columns by admin Pick of the Week’s News: Clinical Trial, Collaboration, Oral DMTs, Resilience, Cannabis Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. MS Patients with Spasticity Needed for Study of Extended-release Baclofen Capsules Now here’s a rare chance to get involved in a clinical trial – as long as you have MS and experience some form…
January 16, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Partners, Traffic, Patent, B-cells, Award Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. Sanofi, ImmuNext Partner to Develop Antibody to Treat Range of Autoimmune Diseases Big news on the business front is the alliance of two companies, Sanofi and ImmuNext, that have announced an agreement…
January 9, 2017 Columns by admin MS Patient’s Pick of the Week’s News: Diet and Exercise, Tolerability, CHANGE-MS and More Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Inactivity and Poor Diet Are Common Risk Factors Among MS Patients, Study Says For years, people with MS have been advised to exercise more and eat healthy foods. That is advice given to…
December 19, 2016 Columns by admin MS Patient’s Picks of the Week’s News: Zinbryta, Gadolinum, Calcium, Brain’s Defense, Antibiotic Here are my Picks of the Week’s News, as published by Multiple Sclerosis News Today. Zinbryta Approved in Canada as Once-Monthly Treatment for Relapsing MS It can only be good for people with relapsing MS in Canada that they now may receive Zinbryta as a treatment.
December 12, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Imbalances, Attack, Hormonal, Vitamin D, Copaxone Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Imbalances in Brain Microbiota May Be Behind Demyelination in MS, Study Says Good to see that new research involving humans (NOT mice this time) may lead to better understanding of MS. Alterations…
December 5, 2016 Columns by admin MS Patient’s Pick of the Week’s News: UV light, Parasite Protein, Copper, Stem Cells, Palliative Here is my Pick of the Week’s news, as published in Multiple Sclerosis News Today. UV Light May Lead Way to New Treatment for MS and Inflammation Now this might be exciting, if turns out that ultraviolet light can truly be the basis of new treatments that…
November 28, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Stem Cells, Sun Scares, T-Cells, and More This is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. New Company Specializing in Stem Cell Platform for MS and Other Ills Raises $48.5M A news story about a new company raising nearly $50 million to further develop stem cell transplants that…
November 21, 2016 Columns by admin MS Patient’s Pick of the Week’s News: DMTs, Availability, Cannabis, Imaging, Sexual Dysfunction Here is my Pick of the Week’s News as published by Multiple Sclerosis News Today. Effectiveness and Safety of DMDs Top Patient Concerns with These Therapies, Survey Says Having progressive multiple sclerosis, the issue of drugs that are disease modifying therapies (DMTs) has never arisen in my…
November 14, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Immunity, Marijuana, Late-onset, Genetics and Reimbursements Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Immune System May Harbor Natural Way of Fighting MS, Other Autoimmune Diseases A genetic key to a possible natural way of battling MS could be worth further work. A variant in the TYK2 gene, which encodes…
November 7, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Ampyra, Breast Cancer, Bourbon, Myelin, Lemtrada Here’s my Pick of the Week’s News published last week in Multiple Sclerosis News Today. Ampyra Helps MS Patients Not Only Walk Better, But Feel Better Too, Study Reports This is news of encouraging research. Results from a Phase 2 clinical trial showed that treatment with Ampyra (prolonged-release fampridine)…
October 31, 2016 News by admin MS Patient’s Pick of the Week’s News: Myelin, Posture, ‘Rare’ Molecule, T-cells, CBDs This is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Study of Myelin-producing Cells a Step Forward for MS, Other Neurological Disorders Isn’t it strange how often in the world of science, something of importance is found in an unconnected study? Here,…
October 24, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Lemtrada, Umbilical Stem Cells, Wheat Proteins and Research Here is my pick of the week’s news items, as published in Multiple Sclerosis News Today. Lemtrada Seen to Help Reverse MS Disability in People in Earlier Stages of Disease A medication that might not just stop but reverse disability of people with relapsing MS? Now, this is…
October 17, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Remyelination, Ocrevus, Mushrooms, Heparin, Exercise Here, I comment on my Pick of the Week’s News, as published in Multiple Sclerosis News Today. Myelin Regeneration Achieved in Mouse Model of MS Remyelination is one of the most exciting developments in the treatment of MS. Therapies aimed at regenerating the myelin sheath can work to…
October 10, 2016 Columns by Ed Tobias MS Patient’s Pick of the Week’s News: Viruses and MS, New Therapy Device, Tysabri vs. Gilenya and More I’m filling in for Ian Franks this week on news item picks for Multiple Sclerosis News Today while Ian is in Moscow taking the first step in his HSCT (hematopoietic stem cell transplantation) quest. We wish him well. Virus Linked to Respiratory Infections May Also Trigger Brain Diseases…
October 3, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Tecfidera, T-cells, Test Dosing and More Here’s my pick of this week’s news, as published in Multiple Sclerosis News Today. How Tecfidera Works to Reduce MS Relapses Finally Discovered, May Lead to Better Treatments The possibility that this discovery may lead to the development of new drugs with fewer side effects is good news.
September 26, 2016 Columns by admin MS Patient’s Pick of the Week’s News: Most Effective, Brain MRIs, Vit D3, Lipoic Acid, Modeling Here’s my Pick of this Week’s News, as published by Multiple Sclerosis News Today. This week is a rather special one because it spotlights the work done by our news team in following and reporting the major events at ECTRIMS 2016. Here, I set out my choice of what I…
September 19, 2016 Columns by admin MS Columnist’s Picks of the Week: ECTRIMS, Biomarkers, Cannabis, Migraine, Research Award Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. #ECTRIMS2016 was undoubtedly the star of the week ECTRIMS, the European Committee for Treatment and Research in Multiple Sclerosis, dominated the news stories of the week when it held its 32nd congress in London. There…
